Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,652 | -55,365 | -47,166 | -36,633 | -23,484 |
| Depreciation Amortization | 1,798 | 7,654 | 5,802 | 3,977 | 2,051 |
| Income taxes - deferred | 11 | 4 | 75 | 37 | 37 |
| Accounts receivable | 1,982 | 2,300 | 3,293 | -475 | 3,146 |
| Accounts payable and accrued liabilities | 1,532 | -3,017 | -3,016 | -1,991 | -1,029 |
| Other Working Capital | 3,542 | -11,844 | -12,759 | -10,861 | -7,487 |
| Other Operating Activity | -427 | 16,165 | 12,650 | 14,081 | 5,942 |
| Operating Cash Flow | $-7,214 | $-44,103 | $-41,121 | $-31,865 | $-20,824 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,248 | -21,595 | -25,330 | -38,783 | -48,007 |
| PPE Investments | -204 | -2,456 | -1,414 | -980 | -810 |
| Investing Cash Flow | $16,044 | $-24,051 | $-26,744 | $-39,763 | $-48,817 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -180 | -1,022 | -520 | -354 | -181 |
| Common Stock Issued | 7 | 91 | 75 | 59 | 36 |
| Other Financing Activity | -77 | -2,274 | -2,274 | -2,274 | -299 |
| Financing Cash Flow | $-250 | $-3,205 | $-2,719 | $-2,569 | $-444 |
| Beginning Cash Position | 12,465 | 83,824 | 83,824 | 83,824 | 83,824 |
| End Cash Position | 21,045 | 12,465 | 13,240 | 9,627 | 13,739 |
| Net Cash Flow | $8,580 | $-71,359 | $-70,584 | $-74,197 | $-70,085 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,214 | -44,103 | -41,121 | -31,865 | -20,824 |
| Capital Expenditure | -204 | -2,456 | -1,414 | -980 | -810 |
| Free Cash Flow | -7,418 | -46,559 | -42,535 | -32,845 | -21,634 |